Differential involvement of E2A-corepressor interactions in distinct leukemogenic pathways

Nucleic Acids Research

Volumn 42, Issue 1, 2014, Pages 137-152

  Gow, Chien Hung ^a   Guo, Chun ^a   Wang, David ^a   Hu, Qiande ^a   Zhang, Jinsong ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; HISTONE ACETYLTRANSFERASE PCAF; PEPTIDES AND PROTEINS; PROTEIN ETO; PROTEIN HEB E; TRANSCRIPTION FACTOR E2A; TRANSCRIPTION FACTOR PBX1; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG; ACTIVATION DOMAIN 1 PROTEIN; COREPRESSOR PROTEIN; EIGHT TWENTY ONE PROTEIN; HELA E BOX BINDING PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL TRANSFORMATION; CONTROLLED STUDY; DNA FLANKING REGION; GENE ACTIVATION; GENE REPRESSION; GENE SILENCING; LEUKEMOGENESIS; MOLECULAR MODEL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; 3T3 CELL LINE; CHROMATIN IMMUNOPRECIPITATION; COLONY FORMATION; HEK293 CELL LINE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOLECULAR DOCKING; PLASMID; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84891785359     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt855     Document Type: Article

References (82)

1. Murre, C., Bain, G., van Dijk, M.A., Engel, I., Furnari, B.A., Massari, M.E., Matthews, J.R., Quong, M.W., Rivera, R.R. and Stuiver, M.H. (1994) Structure and function of helix-loop-helix proteins. Biochim. Biophys. Acta, 1218, 129-135
2. Massari, M.E. and Murre, C. (2000) Helix-loop-helix proteins: Regulators of transcription in eucaryotic organisms. Mol. Cell. Biol., 20, 429-440
3. Kee, B.L., Quong, M.W. and Murre, C. (2000) E2A proteins: Essential regulators at multiple stages of B-cell development. Immunol. Rev., 175, 138-149
4. Bain, G., Maandag, E.C., Izon, D.J., Amsen, D., Kruisbeek, A.M., Weintraub, B.C., Krop, I., Schlissel, M.S., Feeney, A.J., van Roon, M. et al. (1994) E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell, 79, 885-892.
5. Zhuang, Y., Soriano, P. and Weintraub, H. (1994) The helix-loophelix gene E2A is required for B cell formation. Cell, 79, 875-884
6. Quong, M.W., Romanow, W.J. and Murre, C. (2002) E protein function in lymphocyte development. Annu. Rev. Immunol., 20, 301-322
7. Cisse, B., Caton, M.L., Lehner, M., Maeda, T., Scheu, S., Locksley, R., Holmberg, D., Zweier, C., den Hollander, N.S., Kant, S.G. et al. (2008) Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell, 135, 37-48
8. Bhalla, S., Spaulding, C., Brumbaugh, R.L., Zagort, D.E., Massari, M.E., Murre, C. and Kee, B.L. (2008) differential roles for the E2A activation domains in B lymphocytes and macrophages. J. Immunol., 180, 1694-1703
9. Jankovic, V., Ciarrocchi, A., Boccuni, P., DeBlasio, T., Benezra, R. and Nimer, S.D. (2007) Id1 restrains myeloid commitment, maintaining the self-renewal capacity of hematopoietic stem cells. Proc. Natl Acad. Sci. USA, 104, 1260-1265
10. Cochrane, S.W., Zhao, Y., Welner, R.S. and Sun, X.H. (2008) Balance between Id and E proteins regulates myeloid versus lymphoid lineage decisions. Blood, 29, 1016-1026
11. Dias, S., Mansson, R., Gurbuxani, S., Sigvardsson, M. and Kee, B.L. (2008) E2A proteins promote development of lymphoid-primed multipotent progenitors. Immunity, 29, 217-227
12. Kondo, M. (2008) Multitalented E2A: A new role in lymphoidlineage priming. Immunity, 29, 169-170
13. Peverali, F.A., Ramqvist, T., Saffrich, R., Pepperkok, R., Barone, M.V. and Philipson, L. (1994) Regulation of G1 progression by E2A and Id helix-loop-helix proteins. EMBO J., 13, 4291-4301
14. Prabhu, S., Ignatova, A., Park, S.T. and Sun, X.H. (1997) Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins. Mol. Cell. Biol., 17, 5888-5896
15. Park, S.T., Nolan, G.P. and Sun, X.H. (1999) Growth inhibition and apoptosis due to restoration of E2A activity in T cell acute lymphoblastic leukemia cells. J. Exp. Med., 189, 501-508
16. Engel, I. and Murre, C. (1999) Ectopic expression of E47 or E12 promotes the death of E2A-deficient lymphomas. Proc. Natl Acad. Sci. USA, 96, 996-1001
17. Bain, G., Engel, I., Robanus Maandag, E.C., te Riele, H.P., Voland, J.R., Sharp, L.L., Chun, J., Huey, B., Pinkel, D. and Murre, C. (1997) E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas. Mol. Cell. Biol., 17, 4782-4791
18. Yan, W., Young, A.Z., Soares, V.C., Kelley, R., Benezra, R. and Zhuang, Y. (1997) High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice. Mol. Cell. Biol., 17, 7317-7327
19. Aronheim, A., Shiran, R., Rosen, A. and Walker, M.D. (1993) The E2A gene product contains two separable and functionally distinct transcription activation domains. Proc. Natl Acad. Sci. USA, 90, 8063-8067
20. Quong, M.W., Massari, M.E., Zwart, R. and Murre, C. (1993) A new transcriptional-Activation motif restricted to a class of helixloop- helix proteins is functionally conserved in both yeast and mammalian cells. Mol. Cell. Biol., 13, 792-800
21. Massari, M.E., Jennings, P.A. and Murre, C. (1996) The AD1 transactivation domain of E2A contains a highly conserved helix which is required for its activity in both Saccharomyces cerevisiae and mammalian cells. Mol. Cell. Biol., 16, 121-129
22. Massari, M.E., Grant, P.A., Pray-Grant, M.G., Berger, S.L., Workman, J.L. and Murre, C. (1999) A conserved motif present in a class of helix-loop-helix proteins activates transcription by direct recruitment of the SAGA complex. Mol. Cell, 4, 63-73
23. Bradney, C., Hjelmeland, M., Komatsu, Y., Yoshida, M., Yao, T.P. and Zhuang, Y. (2003) Regulation of E2A activities by histone acetyltransferases in B lymphocyte development. J. Biol. Chem., 278, 2370-2376
24. Bayly, R., Chuen, L., Currie, R.A., Hyndman, B.D., Casselman, R., Blobel, G.A. and LeBrun, D.P. (2004) E2A-PBX1 interacts directly with the KIX domain of CBP/p300 in the induction of proliferation in primary hematopoietic cells. J. Biol. Chem., 279, 55362-55371
25. Zhang, J., Kalkum, M., Yamamura, S., Chait, B.T. and Roeder, R.G. (2004) E protein silencing by the leukemogenic AML1-ETO fusion protein. Science, 305, 1286-1289
26. Guo, C., Hu, Q., Yan, C. and Zhang, J. (2009) Multivalent binding of the ETO corepressor to E proteins facilitates dual repression controls targeting chromatin and the basal transcription machinery. Mol. Cell. Biol., 29, 2644-2657
27. Kawashima, N., Shimada, A., Taketani, T., Hayashi, Y., Yoshida, N., Matsumoto, K., Takahashi, Y., Kojima, S. and Kato, K. (2012) Childhood acute myeloid leukemia with bone marrow eosinophilia caused by t(16;21)(q24;q22). Int. J. Hematol., 95, 577-580
28. Peterson, L.F. and Zhang, D.E. (2004) The 8;21 translocation in leukemogenesis. Oncogene, 23, 4255-4262
29. Salomon-Nguyen, F., Busson-Le Coniat, M., Lafage Pochitaloff, M., Mozziconacci, J., Berger, R. and Bernard, O.A. (2000) AML1- MTG16 fusion gene in therapy-related acute leukemia with t(16;21)(q24;q22): Two new cases. Leukemia, 14, 1704-1705
30. Hug, B.A. and Lazar, M.A. (2004) ETO interacting proteins. Oncogene, 23, 4270-4274
31. Yan, M., Burel, S.A., Peterson, L.F., Kanbe, E., Iwasaki, H., Boyapati, A., Hines, R., Akashi, K. and Zhang, D.E. (2004) Deletion of an AML1-ETO C-Terminal NcoR/SMRT-interacting region strongly induces leukemia development. Proc. Natl Acad. Sci. USA, 101, 17186-17191
32. Yan, M., Kanbe, E., Peterson, L.F., Boyapati, A., Miao, Y., Wang, Y., Chen, I.M., Chen, Z., Rowley, J.D., Willman, C.L. et al. (2006) A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis. Nat. Med., 12, 945-949
33. Gelmetti, V., Zhang, J., Fanelli, M., Minucci, S., Pelicci, P.G. and Lazar, M.A. (1998) Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Mol. Cell. Biol., 18, 7185-7191
34. Lutterbach, B., Westendorf, J.J., Linggi, B., Patten, A., Moniwa, M., Davie, J.R., Huynh, K.D., Bardwell, V.J., Lavinsky, R.M., Rosenfeld, M.G. et al. (1998) ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Mol. Cell. Biol., 18, 7176-7184
35. Zhang, J., Hug, B.A., Huang, E.Y., Chen, C.W., Gelmetti, V., Maccarana, M., Minucci, S., Pelicci, P.G. and Lazar, M.A. (2001) Oligomerization of ETO is obligatory for corepressor interaction. Mol. Cell. Biol., 21, 156-163
36. Plevin, M.J., Zhang, J., Guo, C., Roeder, R.G. and Ikura, M. (2006) The acute myeloid leukemia fusion protein AML1-ETO targets E proteins via a paired amphipathic helix-like TBP-Associated factor homology domain. Proc. Natl Acad. Sci. USA, 103, 10242-10247
37. Scheele, J.S., Kolanczyk, M., Gantert, M., Zemojtel, T., Dorn, A., Sykes, D.B., Mobest, D.C., Kamps, M.P and Rapple, D. (2009) The Spt-Ada-Gcn5- Acetyltransferase complex interaction motif of E2a is essential for a subset of transcriptional and oncogenic properties of E2a-Pbx1. Leuk Lymphoma, 50, 816-828
38. Holmlund, T., Lindberg, M.J., Grander, D. and Wallberg, A.E. (2013) GCN5 acetylates and regulates the stability of the oncoprotein E2A-PBX1 in acute lymphoblastic leukemia. Leukemia, 27, 578-585
39. Skerjanc, I.S., Truong, J., Filion, P. and McBurney, M.W. (1996) A splice variant of the ITF-2 transcript encodes a transcription factor that inhibits MyoD activity. J. Biol. Chem., 271, 3555-3561
40. Petropoulos, H. and Skerjanc, I.S. (2000) Analysis of the inhibition of MyoD activity by ITF-2B and full-length E12/E47. J. Biol. Chem., 275, 25095-25101
41. Markus, M., Du, Z. and Benezra, R. (2002) Enhancer-specific modulation of E protein activity. J. Biol. Chem., 277, 6469-6477
42. Bayly, R. and LeBrun, D.P. (2000) Role for homodimerization in growth deregulation by E2a fusion proteins. Mol. Cell. Biol., 20, 5789-5796
43. Bayly, R., Murase, T., Hyndman, B.D., Savage, R., Nurmohamed, S., Munro, K., Casselman, R., Smith, S.P. and LeBrun, D.P. (2006) Critical role for a single leucine residue in leukemia induction by E2A-PBX1. Mol. Cell. Biol., 26, 6442-6452
44. Knoepfler, P.S., Bergstrom, D.A., Uetsuki, T., Dac-Korytko, I., Sun, Y.H., Wright, W.E., Tapscott, S.J. and Kamps, M.P. (1999) A conserved motif N-Terminal to the DNA-binding domains of myogenic bHLH transcription factors mediates cooperative DNA binding with pbx-Meis1/Prep1. Nucleic Acids Res., 27, 3752-3761
45. Fu, X. and Kamps, M.P. (1997) E2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts. Mol. Cell. Biol., 17, 1503-1512
46. Monica, K., LeBrun, D.P., Dedera, D.A., Brown, R. and Cleary, M.L. (1994) Transformation properties of the E2a-Pbx1 chimeric oncoprotein: Fusion with E2a is essential, but the Pbx1 homeodomain is dispensable. Mol. Cell. Biol., 14, 8304-8314
47. Kamps, M.P., Look, A.T. and Baltimore, D. (1991) The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials. Genes Dev., 5, 358-368
48. Fischer, M.A., Moreno-Miralles, I., Hunt, A., Chyla, B.J. and Hiebert, S.W. (2012) Myeloid translocation gene 16 is required for maintenance of haematopoietic stem cell quiescence. EMBO J., 31, 1494-1505
49. Hunt, A., Fischer, M., Engel, M.E. and Hiebert, S.W. (2011) Mtg16/Eto2 contributes to murine T-cell development. Mol. Cell. Biol., 31, 2544-2551
50. Cai, Y., Xu, Z., Xie, J., Ham, A.J., Koury, M.J., Hiebert, S.W. and Brandt, S.J. (2009) Eto2/MTG16 and MTGR1 are heteromeric corepressors of the TAL1/SCL transcription factor in murine erythroid progenitors. Biochem. Biophys. Res. Commun., 390, 295-301
51. Goardon, N., Lambert, J.A., Rodriguez, P., Nissaire, P., Herblot, S., Thibault, P., Dumenil, D., Strouboulis, J., Romeo, P.H. and Hoang, T. (2006) ETO2 coordinates cellular proliferation and differentiation during erythropoiesis. EMBO J., 25, 357-366
52. Denis, C.M., Chitayat, S., Plevin, M.J., Wang, F., Thompson, P., Liu, S., Spencer, H.L., Ikura, M., LeBrun, D.P. and Smith, S.P. (2012) Structural basis of CBP/p300 recruitment in leukemia induction by E2A-PBX1. Blood, 120, 3968-3977
53. Eswar, N., Webb, B., Marti-Renom, M.A., Madhusudhan, M.S., Eramian, D., Shen, M.Y., Pieper, U. and Sali, A. (2006) Comparative protein structure modeling using MODELLER. Curr. Protoc. Bioinformatics, Chapter 5, Unit 5.6
54. Yang, Z., Lasker, K., Schneidman-Duhovny, D., Webb, B., Huang, C.C., Pettersen, E.F., Goddard, T.D., Meng, E.C., Sali, A. and Ferrin, T.E. (2012) UCSF Chimera, MODELLER, and IMP: An integrated modeling system. J. Struct. Biol., 179, 269-278
55. Wei, Y., Liu, S., Lausen, J., Woodrell, C., Cho, S., Biris, N., Kobayashi, N., Wei, Y., Yokoyama, S. and Werner, M.H. (2007) A TAF4-homology domain from the corepressor ETO is a docking platform for positive and negative regulators of transcription. Nat. Struct. Mol. Biol., 14, 653-661
56. Park, S., Chen, W., Cierpicki, T., Tonelli, M., Cai, X., Speck, N.A. and Bushweller, J.H. (2009) Structure of the AML1-ETO eTAFH domain-HEB peptide complex and its contribution to AML1- ETO activity. Blood, 113, 3558-3567
57. de Vries, S.J., van Dijk, M. and Bonvin, A.M. (2010) The HADDOCK web server for data-driven biomolecular docking. Nat. Protoc., 5, 883-897
58. Dominguez, C., Boelens, R. and Bonvin, A.M. (2003) HADDOCK: A protein-protein docking approach based on biochemical or biophysical information. J. Am. Chem. Soc., 125, 1731-1737
59. Schuh, A.H., Tipping, A.J., Clark, A.J., Hamlett, I., Guyot, B., Iborra, F.J., Rodriguez, P., Strouboulis, J., Enver, T., Vyas, P. et al. (2005) ETO-2 associates with SCL in erythroid cells and megakaryocytes and provides repressor functions in erythropoiesis. Mol. Cell. Biol., 25, 10235-10250
60. Geng, H., Brennan, S., Milne, T.A., Chen, W.Y., Li, Y., Hurtz, C., Kweon, S.M., Zickl, L., Shojaee, S., Neuberg, D. et al. (2012) Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-Acute lymphoblastic leukemia. Cancer Discov., 2, 1004-1023
61. Nie, L., Xu, M., Vladimirova, A. and Sun, X.H. (2003) Notchinduced E2A ubiquitination and degradation are controlled by MAP kinase activities. EMBO J., 22, 5780-5792
62. Dragone, L.L., Myers, M.D., White, C., Sosinowski, T. and Weiss, A. (2006) SRC-like adaptor protein regulates B cell development and function. J. Immunol., 176, 335-345
63. Sosinowski, T., Pandey, A., Dixit, V.M. and Weiss, A. (2000) Srclike adaptor protein (SLAP) is a negative regulator of T cell receptor signaling. J. Exp. Med., 191, 463-474
64. Valk, P.J., Verhaak, R.G., Beijen, M.A., Erpelinck, C.A., Barjesteh van Waalwijk van Doorn-Khosrovani, S., Boer, J.M., Beverloo, H.B., Moorhouse, M.J., van der Spek, P.J., Lowenberg, B. et al. (2004) Prognostically useful gene-expression profiles in acute myeloid leukemia. N. Eng. J. Med., 350, 1617-1628
65. Black, J.C., Choi, J.E., Lombardo, S.R. and Carey, M. (2006) A mechanism for coordinating chromatin modification and preinitiation complex assembly. Mol. Cell, 23, 809-818
66. Sanda, T., Lawton, L.N., Barrasa, M.I., Fan, Z.P., Kohlhammer, H., Gutierrez, A., Ma, W., Tatarek, J., Ahn, Y., Kelliher, M.A. et al. (2012) Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia. Cancer Cell, 22, 209-221
67. Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y.C., Laslo, P., Cheng, J.X., Murre, C., Singh, H. and Glass, C.K. (2010) Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell, 38, 576-589
68. Ying, J., Srivastava, G., Hsieh, W.S., Gao, Z., Murray, P., Liao, S.K., Ambinder, R. and Tao, Q. (2005) The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors. Clin. Cancer Res., 11, 6442-6449
69. Schwartz, R., Engel, I., Fallahi-Sichani, M., Petrie, H.T. and Murre, C. (2006) Gene expression patterns define novel roles for E47 in cell cycle progression, cytokine-mediated signaling, and T lineage development. Proc. Natl Acad. Sci. USA, 103, 9976-9981
70. Zhang, J. and Lazar, M.A. (2000) The mechanism of action of thyroid hormones. Annu. Rev. Physiol., 62, 439-466
71. Lee, C.C., Chen, W.S., Chen, C.C., Chen, L.L., Lin, Y.S., Fan, C.S. and Huang, T.S. (2012) TCF12 protein functions as transcriptional repressor of E-cadherin, and its overexpression is correlated with metastasis of colorectal cancer. J. Biol. Chem., 287, 2798-2809
72. Chatterjee, M., Rauen, T., Kis-Toth, K., Kyttaris, V.C., Hedrich, C.M., Terhorst, C. and Tsokos, G.C. (2012) Increased expression of SLAM receptors SLAMF3 and SLAMF6 in systemic lupus erythematosus T lymphocytes promotes Th17 differentiation. J. Immunol., 188, 1206-1212
73. Chatterjee, M., Hedrich, C.M., Rauen, T., Ioannidis, C., Terhorst, C. and Tsokos, G.C. (2012) CD3-T cell receptor co-stimulation through SLAMF3 and SLAMF6 receptors enhances RORgammat recruitment to the IL17A promoter in human T lymphocytes. J. Biol. Chem., 287, 38168-38177
74. Liebermann, D.A., Tront, J.S., Sha, X., Mukherjee, K., Mohamed- Hadley, A. and Hoffman, B. (2011) Gadd45 stress sensors in malignancy and leukemia. Crit. Rev. Oncog., 16, 129-140
75. Ju, S., Zhu, Y., Liu, L., Dai, S., Li, C., Chen, E., He, Y., Zhang, X. and Lu, B. (2009) Gadd45b and Gadd45g are important for antitumor immune responses. Eur. J. Immunol., 39, 3010-3018
76. Vairapandi, M., Balliet, A.G., Hoffman, B. and Liebermann, D.A. (2002) GADD45b and GADD45g are cdc2/cyclinB1 kinase inhibitors with a role in S and G2/M cell cycle checkpoints induced by genotoxic stress. J. Cell Physiol., 192, 327-338
77. Vos, M.D., Ellis, C.A., Elam, C., Ulku, A.S., Taylor, B.J. and Clark, G.J. (2003) RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor. J. Biol. Chem., 278, 28045-28051
78. Song, H., Oh, S., Oh, H.J. and Lim, D.S. (2010) Role of the tumor suppressor RASSF2 in regulation of MST1 kinase activity. Biochem. Biophys. Res. Commun., 391, 969-973
79. Dragone, L.L., Shaw, L.A., Myers, M.D. and Weiss, A. (2009) SLAP, a regulator of immunoreceptor ubiquitination, signaling, and trafficking. Immunol. Rev., 232, 218-228
80. Birney, E., Stamatoyannopoulos, J.A., Dutta, A., Guigo, R., Gingeras, T.R., Margulies, E.H., Weng, Z., Snyder, M., Dermitzakis, E.T., Thurman, R.E. et al. (2007) Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature, 447, 799-816
81. Ptasinska, A., Assi, S.A., Mannari, D., James, S.R., Williamson, D., Dunne, J., Hoogenkamp, M., Wu, M., Care, M., McNeill, H. et al. (2012) Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding. Leukemia, 26, 1829-1841
82. Martens, J.H., Mandoli, A., Simmer, F., Wierenga, B.J., Saeed, S., Singh, A.A., Altucci, L., Vellenga, E. and Stunnenberg, H.G. (2012) ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia. Blood, 120, 4038-4048